Glioblastoma Multiforme
Showing NaN - NaN of 43
Glioblastoma Multiforme Trial in United States (Amgen 386, Bevacizumab)
Glioblastoma Multiforme Trial in Worldwide (NovoTTF-100A device, Temozolomide)
Completed
- Glioblastoma Multiforme
- NovoTTF-100A device
- Temozolomide
-
Birmingham, Alabama
- +88 more
Apr 7, 2017
Glioblastoma Multiforme Trial in United States (ICT-107, Placebo DC)
Completed
- Glioblastoma Multiforme
- ICT-107
- Placebo DC
-
South Birmingham, Alabama
- +24 more
Feb 10, 2017
Gliomas, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Los Angeles (alloreactive CTL)
Completed
- Gliomas
- +5 more
- alloreactive CTL
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
May 26, 2016
Advanced Malignant Glioma, Anaplastic Astrocytomas, Glioblastoma Multiforme Trial in Australia, United States (AMG 595)
Completed
- Advanced Malignant Glioma
- +2 more
- AMG 595
-
Los Angeles, California
- +3 more
Apr 14, 2016
GBM, Glioblastoma Multiforme Trial in United States (DCVax-L)
Available
- GBM
- Glioblastoma Multiforme
- DCVax-L
-
Little Rock, Arkansas
- +26 more
Feb 25, 2016
Mixed Gliomas, Malignant Gliomas, Glioblastoma Multiforme Trial in United States (XL765 (SAR245409), Temozolomide)
Completed
- Mixed Gliomas
- +2 more
- XL765 (SAR245409)
- Temozolomide
-
Birmingham, Alabama
- +5 more
Apr 9, 2013
Glioblastoma Multiforme Trial in United States (Everolimus, Surgery)
Glioblastoma Multiforme Trial in United States (MPC-6827 + Carboplatin)
Unknown status
- Glioblastoma Multiforme
- MPC-6827 + Carboplatin
-
Los Angeles, California
- +4 more
Mar 24, 2011
Malignant Glioma, Glioblastoma Multiforme, GBM Trial in United States (131-I-TM-601, 131I-TM601)
Unknown status
- Malignant Glioma
- +5 more
-
Birmingham, Alabama
- +18 more
Apr 1, 2009